Related Experiment Video
Updated: Apr 21, 2026
10:35
Surface Passivation for Single-molecule Protein Studies
Published on: April 24, 2014
42.8K
Site-specific PEGylation of proteins: recent developments.
Nicole Nischan1, Christian P R Hackenberger
1Leibniz-Institut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Strasse 10, 13125 Berlin, Germany.
The Journal of Organic Chemistry
|October 22, 2014
Summary
Attaching polyethylene glycol (PEG) to proteins stabilizes them for medical use. New site-specific methods create uniform PEGylation, enhancing protein drug effectiveness and improving how the body uses peptide and protein therapeutics.
Area of Science:
- Biochemistry
- Pharmaceutical Science
- Drug Development
Background:
- Polyethylene glycol (PEG) attachment to peptides and proteins is crucial for stabilizing them in vivo.
- Conventional PEGylation methods often yield heterogeneous mixtures, reducing protein activity and therapeutic efficacy.
- Developing site-specific PEGylation strategies is essential for improving protein-drug development.
Purpose of the Study:
- To highlight recent advancements in site-specific PEGylation techniques for peptides and proteins.
- To discuss strategies for improving PEG architecture and targeting specific amino acids.
- To review the impact of advanced PEGylation on the pharmacokinetics of protein therapeutics.
Main Methods:
- Chemoselective targeting of canonical and noncanonical amino acids for PEG attachment.
- Development of improved PEG architectures for enhanced stability and function.
- Evaluation of pharmacokinetic profiles of PEGylated peptide and protein therapeutics.
Main Results:
- Achieved site-specific PEGylation, leading to homogeneous mixtures.
- Demonstrated improved protein activity compared to conventional methods.
- Observed enhanced pharmacokinetic properties of peptide and protein therapeutics.
Conclusions:
- Site-specific PEGylation represents a significant advancement in pharmaceutical research.
- Improved PEGylation strategies enhance the stability and efficacy of protein-based drugs.
- Advanced PEGylation techniques offer a promising route for developing effective peptide and protein therapeutics with better in vivo performance.
More Related Videos
Related Concept Videos
01:24Tagging and Fusion Proteins
6.3K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
6.3K
01:25Protein Glycosylation
8.2K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
8.2K
02:04Covalently Linked Protein Regulators
8.2K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.2K
01:26Protein Modifications in the RER
5.5K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.5K
01:32Lipids as Anchors
5.9K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.9K
00:49Ligand Binding and Linkage
4.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.4K